A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
OHSU Knight Cancer Institute
First Affiliated Hospital of Zhejiang University
NYU Langone Health